The NRG Fusion Market represents a cutting-edge and highly specialized sector within precision oncology, concentrating on targeting gene fusions involving neuregulin (NRG) family genes. Gene fusions, particularly those involving NRG1, have been recognized as cancer-driving alterations across various solid tumors, including non-small cell lung cancer (NSCLC), pancreatic cancer, breast...